Our estimates remain broadly in line with the company's double-digit growth guidance and improving margins, supported by capex monetisation. We continue to value the stock at a 51x FY28E to arrive at a TP of Rs 1,750/share, implying an upside of 21% from the CMP. We maintain our BUY rating.